China Universal Asset Management Co., Ltd. Biogen Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 30,584 shares of BIIB stock, worth $6.87 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
30,584
Previous 30,584
-0.0%
Holding current value
$6.87 Million
Previous $6.6 Million
0.02%
% of portfolio
0.85%
Previous 0.84%
Shares
12 transactions
Others Institutions Holding BIIB
# of Institutions
1,047Shares Held
126MCall Options Held
1.37MPut Options Held
1.35M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.72 Billion0.07% of portfolio
-
Primecap Management CO Pasadena, CA16.2MShares$3.64 Billion2.65% of portfolio
-
Black Rock Inc. New York, NY14.1MShares$3.18 Billion0.07% of portfolio
-
State Street Corp Boston, MA6.75MShares$1.52 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.17MShares$1.16 Billion0.68% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $32.3B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...